skip to content

Cambridge Academy of Therapeutic Sciences

 
Read more at: Drug incorporated into silicone coating reduces ‘foreign body reaction’ to implants

Drug incorporated into silicone coating reduces ‘foreign body reaction’ to implants

28 April 2022

Long term use of implantable medical devices- such as pacemakers and cochlear implants- is hampered by the body's reaction to foreign bodies. now, in a study in mice, a team led by scientists at the University of Cambridge has shown that this reaction can be dramatically reduced by incorporating an anti-inflammatory drug...

Read more

Read more at: Cambridge spin-out receives European Innovation Council grant to develop cancer imaging technologies

Cambridge spin-out receives European Innovation Council grant to develop cancer imaging technologies

23 February 2022

Spin-off company Cambridge Raman Imaging Ltd. and the Cambridge Graphene Centre will lead ‘CHARM’ project, recently awarded with €3.2 million Funding from the European Union is an integral part of the Cambridge Graphene Centre’s success Andrea Ferrari The European Innovation Council (EIC) has awarded the first Transition...

Read more

Read more at: Study in mice shows potential for gene-editing to tackle mitochondrial disorders

Study in mice shows potential for gene-editing to tackle mitochondrial disorders

16 February 2022

Defective mitochondria – the ‘batteries’ that power the cells of our bodies – could in future be repaired using gene-editing techniques. Scientists at the University of Cambridge have shown that it is possible to modify the mitochondrial genome in live mice, paving the way for new treatments for incurable mitochondrial...

Read more

Read more at: Cambridge spin-out aims to realise the power of genomic data in precision medicine

Cambridge spin-out aims to realise the power of genomic data in precision medicine

7 February 2022

Cambridge spin-out Zetta Genomics has raised £2.5 million in new seed funding from Nina Capital, APEX Medical and Cambridge Enterprise to advance its genomic data management technology and power the discovery and delivery of precision medicine at scale. XetaBase is built on the open-source OpenCB platform, the first proven...

Read more

Read more at: Cambridge coronavirus vaccine enters clinical trial: Needle-free vaccine targets COVID-19 variants and future coronaviruses

Cambridge coronavirus vaccine enters clinical trial: Needle-free vaccine targets COVID-19 variants and future coronaviruses

16 December 2021

Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics. The first volunteer is expected to receive the vaccine today at the NIHR Southampton Clinical Research Facility. Developed by Professor Jonathan...

Read more

Read more at: Large-scale genetic study reveals new clues for the shared origins of irritable bowel syndrome and mental health disorders

Large-scale genetic study reveals new clues for the shared origins of irritable bowel syndrome and mental health disorders

8 November 2021

An international study of more than 50,000 people with irritable bowel syndrome (IBS) has revealed that IBS symptoms may be caused by the same biological processes as conditions such as anxiety. The research highlights the close relationship between brain and gut health and paves the way for development of new treatments...

Read more

Read more at: Whole genome sequencing increases diagnosis of rare disorders by nearly a third

Whole genome sequencing increases diagnosis of rare disorders by nearly a third

8 November 2021

Whole genome sequencing from a single blood test picks up 31% more cases of rare genetic disorders than standard tests, shortening the ‘diagnostic odyssey’ that affected families experience, and providing huge opportunities for future research. A definitive genetic diagnosis can really help patients and their families...

Read more

Read more at: Gut bacteria accumulate many common medications and may reduce their effectiveness

Gut bacteria accumulate many common medications and may reduce their effectiveness

14 September 2021

Common medications can accumulate in gut bacteria, a new study has found, altering bacterial function and potentially reducing the medications’ effectiveness. If we can characterise how people respond depending on the composition of their microbiome, then drug treatments could be individualised Kiran Patil These...

Read more

Read more at: Biological ‘fingerprints’ of long COVID in blood could lead to diagnostic test, say Cambridge scientists

Biological ‘fingerprints’ of long COVID in blood could lead to diagnostic test, say Cambridge scientists

20 July 2021

Markers in our blood – ‘fingerprints’ of infection – could help identify individuals who have been infected by SARS-CoV-2, the coronavirus that causes COVID-19, several months after infection even if the individual had only mild symptoms or showed no symptoms at all, say Cambridge researchers. Because we currently have no...

Read more

Read more at: Apollo Therapeutics launches with £100m investment

Apollo Therapeutics launches with £100m investment

21 June 2021

Pioneering collaboration initiated by the University of Cambridge, Imperial College London and University College London A pioneering collaboration to speed development of breakthrough medical discoveries—devised by the University of Cambridge, Imperial College London, University College London and embraced by...

Read more